Clinical and laboratory features of spontaneous bacterial peritonitis

East African Medical Journal

Volumn 81, Issue 9, 2004, Pages 474-479

  Filik, L ^a   Unal, S ^a  

^a NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; LIVER CIRRHOSIS; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PERITONITIS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PERITONITIS; RETROSPECTIVE STUDIES;

EID: 16644377055     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: 10.4314/eamj.v81i9.9224     Document Type: Article

References (40)

1. Rimola, A., Garcia-Tsao, G., Navasa M. et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J. Hepatol. 2000; 32:142-153.
2. Such, J., and Runyon, B.A. Spontaneous bacterial peritonitis. Clin Inf. Dis. 1998; 27:669-676.
3. Fernandez, J., Bauer, T.M., Navasa, M., and Rodes, J. Diagnosis, treatment and prevention of spontaneous bacterial peritonitis. Baillieres Best Pract. Res. Clin. Gastroenterol. 2000; 14:975-990.
4. Kurtz, R.C., and Bronzo, R.L. Does spontaneous bacterial peritonitis occur in malignant ascites? Amer. J. Gastroenterol. 1982; 77:146-148.
5. Runyon, B.A. Spontaneous bacterial peritonitis associated with cardiac ascites. Amer. J. Gastroenterol., 1984; 79:796.
6. Chu, C-M., Chang, K.Y., and Liaw, Y-F. Prevalance and prognostic significance of bacterascites in cirrhosis with ascites. Dig. Dis. Sci., 1995; 40:561.
7. Garcia-Tsao, G. Spontaneous bacterial peritonitis. Gastroenterology. Clin. of North Amer. 1992; 21:257-275.
8. Andreu, M., Sola, R., Sitges-Serra A., et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology, 1993; 104:1133-1138.
9. Weinstein, M.P., Iannini, P.B., et al. Spontaneous bacterial peritonitis: a review of 28 cases with emphasis on improved survival and factors influencing prognosis. Amer. J. Med., 1978; 64:592-598.
10. Boixeda, D., De Luis, D.A., Aller, R., and De Argila, C.M. Spontaneous bacterial peritonitis: Clinical and microbiological study of 233 episodes. J. Clinical Gastroenterol., 1996; 23:275-279.
11. Saez-Royuela, F., Gomez, Rubio, M., Fernandez, Guerrero, M.L., et al. A microbiological and clinical study of 57 cases of spontaneous bacterial peritonitis in liver cirrhosis patients. Rev. Clin. Esp., 1990; 187:321-324.
12. Aller, R., De Luis, D.A., Boixeda, D., Arocena, C., De Argila, C.M., and Moreira, V. Spontaneous bacterial peritonitis: clinical study, microbiological findings and clinical course. Rev. Esp. Enferm. Dig., 1997; 89:174-185.
13. Mihas, A.A., Toussaint, J., Dotherow, P., and Achord, L. Spontaneous bacterial peritonitis in cirrhosis: Clinical and laboratory features, survival and prognostic indicators. Hepato. Gastroenterol., 1992; 39:520-522.
14. Marelli, A., Nardecchia, L., De Gennaro, F. and Bodini, P. Spontaneous bacterial peritonitis (SBP): prevalence and characteristics in a population of 314 cirrhotic patients evaluated at hospital admission. Minerva Med. 1999; 90:369-375.
15. Llach, J., Rimola, A., Navasa M., et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology, 1992; 16:724-727.
16. Llovet, J.M., Planas, R., Morillas, R., et al. Short term prognosis of cirrhotics with spontaneous bacterial peritonitis: a multivariate study. Amer. J. Gastroenterol., 1993; 88:388-392.
17. Akalm, H.E., Laleli, Y. and Telatar, H. Bactericidal and opsonic activity of the ascitic fluid from cirrhotic and non cirrhotic patients. J. Infec. Dis., 1983; 147:1011-1017.
18. Guarner, C., Sola R., Soriano G., et al. Risk of first community acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology, 1999; 117:414-419.
19. Bleichner, G. Boulanger, R., Squara, P, et al. Frequency of infections in cirrhotic patients in cirrhotic patients presenting acute gastrointestinal hemorrhage. Brit. J. Surg. 1986; 73:724-726.
20. Toledo, J., Salmeron, J.M., Rimola, A., et al. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime. Hepatology, 1993; 17:251-257.
21. Cabrera, J., Arroya, V., Ballesta, A.M., et al. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary β2-microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology, 1982; 100:1737-1742.
22. Felisart, J., Rimola, A., Arroyo, V., et al. Cefotaxime is more effective than ampicillin-tobramycin in cirrhotics with severe infections. Hepatology, 1985; 5:457-462.
23. Runyon, B.A., Hutchison, J.G., Antillon M.R., et al. Short course versus long course antibiotic treatment of spontaneous bacterial peritonitis. Gastroenterology, 1991; 100:1737-1742.
24. Navasa, M., Folio, A., Llovet, J.M., et al. Randomized comperative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastoenterology, 1996; 111:1011-1017.
25. Younossi, Z.M., McHutchinson, J.G., and Ganiata, T.G. An economic analysis of norfloxacin against spontaneous bacterial peritonitis. J. Hepatol., 1997; 27:295-298.
26. Inadomi, J., and Sonnenberg, A. Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis. Gastroenterology, 1997; 113:1289-1294.
27. Runyon, B.A., Canawati, H.N., Akriviadis E.A., et al. Optimization of ascitic fluid culture technique. Gastroenterology, 1988; 95:1351-1355.
28. Bobadilla, M., Sifuentes, J., and Garcia-Tsao, G. Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis. J. Clin. Microbiol., 1989; 27:2145-2147.
29. Castellote, J., Xiol, X., Verdauger, R., et al. Comparison of two ascitic fluid culture methods in cirrhotic patients with spontaneous bacterial peritonitis. Amer. J. Gastroenterol., 1990; 85:1605-1608.
30. Ho H., Guerra, L.G., Zuckerman, M.J., et al. Urinary tract infection: A predisposing factor for spontaneous bacterial peritonitis. Gastroenterology, 1990; 98:593.
31. Barnes, P.F., Arevola, C., Chan, L.S., et al. A prospective evaluation of bacteriemic patients with chronic liver disease. Hepatology. 1988; 8:1099-1103.
32. Rogers, D.E. Host mechanisms which act to remove bacteria from the blood stream. Bact. Rev., 1960; 24:50-66.
33. Caly, W.R., and Strauss, E. A prospective study of bacterial infections in patients with cirrhosis. J. Hepatol., 1993; 18:353-358.
34. Pinzello, G., Simonetti, R., Camma, C., et al. Spontaneous bacterial peritonitis: an update. Gastroenterol. Int., 1993; 6:54-60.
35. Mercader, J., Gomez, J., Ruiz, J., et al. Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients. Chemotherapy, 1989; 35:23-26.
36. Mesquita, M.A., Balbino, E.P.S., Albuquerque, R.S., et al. Ceftriaxone in the treatment of spontaneous bacterial peritonitis: ascitic fluid polymorphonuclear count response and short term prognosis. Hepato. Gastroenterology, 1997; 44:1276-1280.
37. Rimola, A., Tito, L., Llach, J., et al. Efficacy of ceftizoxime in the treatment of severe bacterial infections in patients with cirrhosis. Drug Invest., 1992; 4:35-37.
38. Grange, J.D., Amiot, X., Grange, V., et al. Amoxicillin-clavulanic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients. Hepatology, 1990; 11:360-364.
39. Sing, N., Gayowski T., Yu V.L., et al. Trimethoprim-sulfame thoxazole for prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann. Intern. Med. 1995; 122:595-598.
40. Ricart, E., Soriano G., Novella M.T., et al. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J. Hepatol., 2000; 32:596-602.